Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.
Ikeda
Yoshihiko
Y
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1590, USA.
Taveira-DaSilva
Angelo M
AM
Pacheco-Rodriguez
Gustavo
G
Steagall
Wendy K
WK
El-Chemaly
Souheil
S
Gochuico
Bernadette R
BR
May
Rose M
RM
Hathaway
Olanda M
OM
Li
Shaowei
S
Wang
Ji-an
JA
Darling
Thomas N
TN
Stylianou
Mario
M
Moss
Joel
J
D002455:Cell Division / Q000187:drug effects / Q000502:physiology*; D018450:Disease Progression; D004921:Erythropoietin / Q000494:pharmacology* / Q000502:physiology*; D016147:Genes, Tumor Suppressor; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D018192:Lymphangioleiomyomatosis / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D015398:Signal Transduction / Q000235:genetics; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000172:deficiency / Q000187:drug effects / Q000235:genetics*
C000624650:TSC1 protein, human; C000624653:TSC2 protein, human; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; D004921:Erythropoietin